Dividend RSUs increase Enact Holdings (ACT) COO equity exposure
Rhea-AI Filing Summary
Enact Holdings EVP & Chief Operations Officer Brian Gould reported routine equity compensation activity. On March 19, 2026, he acquired three small grants of restricted stock units (RSUs) totaling 49 units under existing award agreements, triggered by a quarterly dividend of $0.21 per share.
Each RSU will settle into one share of Enact common stock. The RSUs tied to different prior grants vest in three equal annual installments beginning on February 16, 2025, February 21, 2026, and February 13, 2027. No open-market stock purchases or sales were reported in this Form 4.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 11 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 17 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 21 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 16, 2025. Additional restricted stock units acquired pursuant to reinvestment terms in the restricted stock unit award agreement resulting from a quarterly dividend at $0.21 per share, paid on March 19, 2026. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 21, 2026. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 13, 2027.
FAQ
What insider transaction did Enact Holdings (ACT) EVP Brian Gould report?
How many restricted stock units did Enact EVP Brian Gould acquire in this Form 4?
When did Brian Gould’s new Enact Holdings RSUs arise and what triggered them?
How do Brian Gould’s Enact Holdings restricted stock units vest over time?
What is the settlement ratio of Enact Holdings RSUs reported in this filing?
Were there any open-market stock purchases or sales in this Enact (ACT) Form 4?